Your session is about to expire
← Back to Search
Brain Function Study for Epilepsy
Study Summary
This trial will enroll epilepsy patients who have electrodes in their brain or on their scalp, as well as normal and online controls. The aim is to study localization and function of the human brain using intracranial electrophysiology.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years or older and may need a scalp EEG.I am 18 years or older and may have an intracranial EEG.I am 18 years or older and do not have the condition being studied.I have hard-to-treat epilepsy and am undergoing special brain monitoring.I have an intracranial EEG but no other neurological or psychiatric conditions.My EEG results suggest I likely have epilepsy.
- Group 1: Normal Controls
- Group 2: Online Controls
- Group 3: Invasive EEG (electrodes are implanted in a participant's brain)
- Group 4: Scalp EEG (electrodes are placed on a participant's scalp)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are participants still able to join this experiment?
"According to the information found on clinicaltrials.gov, this trial is not open to recruitment at present time. The study was originally posted on November 15th 2022 and has since been updated last October 27th 2022; however, there are an abundance of other research studies actively seeking participants right now - with a total of 239 trials recruiting patients as we speak."
What primary objectives are associated with this research endeavor?
"The primary purpose of this clinical trial is to quantify the alterations in electrical activity within the human brain pertaining to emotions. Additionally, investigators will assess the degree of correlation between brain activation and sweat production, respiratory action, as well as cardiac physiology over a two-week observation period. To record sweat amounts precisely, a Q-SWEAT system with four standardised compartments on areas such as foot dorsum and lower legs will be utilised. Moreover, respirations are monitored by noninvasive sensors around participants' chests and abdomens while heart rate variabilities are recorded using CNAP machines that take pressure measurements sans an arterial line or"
Share this study with friends
Copy Link
Messenger